ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000219665.4	ABT-263 (navitoclax)	Sarcoma	0.020668121	Resistant
ENSG00000219665.4	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.021835994	Sensitive